design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

UCSD Design Lab & the National Cancer Institute organize workshop on Human Systems Integration

On October 20 and 21, the Design Lab jointly organized a workshop with the National…

Design Lab Faculty

New Design Lab Faculty Working to Shape the Future of UC San Diego

As a global pioneer in design thinking, research, and invention, The Design Lab prides itself on recruiting the brightest and most innovative minds in the design field. Today, we would like to extend a warm welcome to brand new faculty members Elizabeth Eikey, Haijun Xia, and Edward Wang!

Elizabeth Eikey
From a first-generation undergraduate student at Penn State, then an inquisitive Best Buy employee and finally, to the Assistant Professor in the Department of Family Medicine and Public Health & The Design Lab at UCSD, Dr. Elizabeth Eikey has an illustrious career. Her research work at The Design Lab focuses on the intersection between technology, mental health, and equity, primarily studying the possible applications for technology in supporting mental health and well-being.

Haijun Xia
After receiving his PhD in Computer Science from University of Toronto, Xia made the move across countries to begin his time as a researcher at UC San Diego. ‘I wanted to work at The Design Lab and UC San Diego, because of the diversity of skill here,’ says the Professor, ‘We are all approaching the many challenging research questions from different angles, which is really important to develop comprehensive solutions.

Edward Wang
When Edward Wang was an undergraduate student at Harvey Mudd, he never expected himself to become a researcher, let alone becoming a professor. It was only after a Professor offered him the chance to help design a course she was planning about biosignal processing, that he began on this path. ‘As I was designing the class over summer, I had to read a bunch of papers,’ he says, ‘I couldn’t stop thinking about how cool all of it was. Especially when it branched out into computer science and how it could be involved in biosignal processes.’
CHI 2019 Conference In Glasgow, Scotland

Design Lab Weaves the Threads of CHI 2019

From May 4-9, 2019, the ACM CHI Conference on Human Factors in Computing Systems took place in Glasgow, Scotland. Called “CHI” for short, this annual and prominent event brings together thousands of the world’s leading researchers, designers, and scientists in human-computer interaction. 

Design Lab members walked away with a number of awards for their research. Post-doctoral Fellow Sarah Fox won a Best Paper Award for “Managerial Visions: Stories of upgrading and maintaining the public restroom with IoT”.

Opinion: Becoming a World Design Capital would improve life in San Diego-Tijuana

San Diego Union Tribune Op-Ed by Mayor Todd Gloria

I believe that San Diego is one of the world’s greatest cities, and together with our sister city Tijuana, we form a dynamic, multicultural area unlike anywhere else. Both as a lifelong San Diegan and the mayor of San Diego, I am proud that our city is one of two finalists in the running to be selected as the World Design Capital in 2024. Earning this designation would highlight the unique character of our binational region and show the entire world that our diversity is our strength.

Just as design has continued to address complex challenges at our border and between our cities, we continue to improve the quality of life in San Diego through thoughtful, human-centered design. The transformation of the Plaza de Panama at Balboa Park, Waterfront Park and Liberty Station are only a few examples of how we’ve begun to think about public space differently in San Diego over the last decade.
Design Lab Self-driving Nissan Toyota Ford Duke Stanford E-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the…

Trolley Stops Designathon UCSD Design Lab

Designathon Seeks to Reimagine Trolley Stops

On April 6+7, 2019, on UC San Diego campus Warren Mall, over 200+ students, neighbors, designers, technologists, and media-makers will come together for the Pepper Canyon Mobility Hub Designathon, an event developing proposals that will support the transformation Pepper Canyon Trolley Station at UCSD campus, currently under construction, into a dynamic, multimodal mobility hub. The event is produced through a partnership between The UC San Diego Design Lab, SANDAG, UC San Diego Campus Planning, the UC San Diego Young Planners’ Society, Sixth College Culture, Art, Technology program, and UC San Diego Urban Planning Program.
Back To Top